Real-world experience of bimekizumab for plaque psoriasis in adult patients with prior exposure to interleukin-17 inhibitors: A 52-week multicenter retrospective review.

Siddhartha Sood Alexander Rimke Brian D Rankin Abrahim Abduelmula Jorge R Georgakopoulos Khalad Maliyar Ahmed Bagit Fernejoy Leung Alim R Devani Ronald Vender Jensen Yeung Vimal H Prajapati

J Am Acad Dermatol

Dermatology Research Institute, Calgary, Alberta, Canada; Division of Dermatology, Department of Medicine, University of Calgary, Calgary, Alberta, Canada; Skin Health & Wellness Centre, Calgary, Alberta, Canada; Division of Dermatology, Department of Medicine, University of Calgary, Calgary, Alberta, Canada; Section of Community Pediatrics, Department of Pediatrics, University of Calgary, Calgary, Alberta, Canada; Section of Pediatric Rheumatology, Department of Pediatrics, University of Calgary, Calgary, Alberta, Canada. Electronic address:

Published: January 2025

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.jaad.2024.12.034	DOI Listing

Publication Analysis

Top Keywords

real-world experience

experience bimekizumab

bimekizumab plaque

plaque psoriasis

psoriasis adult

adult patients

patients prior

prior exposure

exposure interleukin-17

interleukin-17 inhibitors

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!